Brooke Boyer

Appearances

UPADACITINIB FOR THE TREATMENT OF REFRACTORY PEDIATRIC INFLAMMATORY BOWEL DISEASE
Date
May 7, 2023
BACKGROUND: Our team (Xiong et al. 2021) recently developed an infliximab population pharmacokinetic (popPK) model in children and young adults with Crohn’s disease (CD). We found that prediction accuracy improved when all five covariates of drug clearance were included…
Presenter
Noor Nema
Speakers
Noor Dawany
Lindsey Albenberg
Children
Robert Baldassano
Brooke Boyer
Brad Constant
Andrew Grossman
Elana Mitchel
Trusha Patel
Ronen Stein
Judith Kelsen
Maire Conrad
SINGLE CENTER RETROSPECTIVE ANALYSIS OF HEMATOPOIETIC STEM CELL TRANSPLANT IN PATIENTS WITH MONOGENIC INFLAMMATORY BOWEL DISEASE
Date
May 8, 2023
BACKGROUND: Tumor necrosis factor inhibitors (TNFi) are a mainstay of pediatric Crohn’s disease (PCD) therapy; yet not all patients respond, and others lose response over time. Combination therapy with methotrexate may improve response; however, this has not been rigorously evaluated…
Presenter
Alyssa Baccarella
Speakers
Trusha Patel
Brooke Boyer
Noor Dawany
Jennifer Heimall
Nancy Bunin
Kathleen Sullivan
Maire Conrad
Judith Kelsen